Tessellate BIO discovers and develops novel precision oncology medicines with the mission to turn cancer patients into cancer survivors. 

A private preclinical stage biotechnology company, Tessellate BIO is redefining Synthetic Lethality by developing drugs that target unexplored or difficult to drug pathways beyond HRD. 

Headquartered in the Netherlands and with research labs at the Stevenage Bioscience Catalyst, UK, Tessellate BIO is supported by top-tier life science investors BioGeneration Ventures (BGV) and Forbion.

Biotechnology

Life Sciences

Pharmaceutical

Therapeutics

Tessellate BIO

Tessellate BIO's headquarters in Amsterdam, Netherlands

Andree Blaukat

Laurent Rigoreau

Joris Schuurmans

Daniela Couto

Lara Boyd

Asiya Giniatullina

Description

People (1)

Diede Brunen

Jobs